Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation
Published version of a preprint
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Multiple tumor-derived factors are responsible for the accumulation and expansion of immune-suppressing myeloid-derived suppressor cells (MDSC) and M2-like tumor-associated macrophages (TAM) in tumors. Here, we show that treatment of tumor-bearing mice with docetaxel in combination with the phosphatidylserine-targeting antibody 2aG4 potently suppressed the growth and progression of prostate tumors, depleted M2-like TAMs, and MDSCs, and increased the presence of M1-like TAMs and mature dendritic cells in the tumors. In addition, the antibody markedly altered the cytokine balance in the tumor microenvironment from immunosuppressive to immunostimulatory. In vitro studies confirmed that 2aG4 repolarized TAMs from an M2- to an M1-like phenotype and drove the differentiation of MDSCs into M1-like TAMs and functional dendritic cells. These data suggest that phosphatidylserine is responsible for the expansion of MDSCs and M2-like TAMs in tumors, and that bavituximab, a phosphatidylserine-targeting antibody currently in clinical trials for cancer, could reverse this process and reactivate antitumor immunity. Cancer Immunol Res; 1(4); 256–68. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TAMs become predominantly polarized into the alternatively-activated M2-like phenotype that secrete proangiogenic factors (13) and immunosuppressive cytokines that further limit T-helper 1 immune responses (14).”
BackgroundFadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · cited 1×
“TAMs become predominantly polarized into the alternatively activated M2-like phenotype that secrete proangiogenic factors (13) and immunosuppressive cytokines that further limit T-helper 1 immune responses (14).”
BackgroundHuang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Identification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180 · cited 1×
“Tim4-positive cells have been observed to bind microvesicles (47).”
BackgroundCorzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Autoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient Mice
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., & Nagata, S. (2004) · Science · doi:10.1126/science.1094359 · Cited by 992 · cited 1×
“29–32), or indirectly through a variety of bridging proteins (33, 34).”
Background
Research works printed but not linked: 41
- Gabrilovich, 2004, Mechanisms and functional significance of tumour-induced dendritic-cell defects, Nat Rev Immunol, 4, 941, 10.1038/nri1498 · DOI · Paper page
- Yang, 2006, CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells, Cancer Res, 66, 6807, 10.1158/0008-5472.CAN-05-3755 · DOI · Paper page
- Li, 2009, Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1, J Immunol, 182, 240, 10.4049/jimmunol.182.1.240 · DOI · Paper page
- Bronte, 2000, Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells, Blood, 96, 3838, 10.1182/blood.V96.12.3838 · DOI · Paper page
- Filipazzi, 2007, Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine, J Clin Oncol, 25, 2546, 10.1200/JCO.2006.08.5829 · DOI · Paper page
- Kusmartsev, 2003, Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species, J Leukoc Biol, 74, 186, 10.1189/jlb.0103010 · DOI · Paper page
- Kusmartsev, 2005, STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion, J Immunol, 174, 4880, 10.4049/jimmunol.174.8.4880 · DOI · Paper page
- Troy, 1998, Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer, J Urol, 160, 214, 10.1016/S0022-5347(01)63093-3 · DOI
- Murdoch, 2005, Macrophage migration and gene expression in response to tumor hypoxia, Int J Cancer, 117, 701, 10.1002/ijc.21422 · DOI · Paper page
- Kurahara, 2011, Significance of M2-polarized tumor-associated macrophage in pancreatic cancer, J Surg Res, 167, e211, 10.1016/j.jss.2009.05.026 · DOI · Paper page
- Yoshikawa, 2012, Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head, Cancer Sci, 103, 2012, 10.1111/j.1349-7006.2012.02411.x · DOI
- Ma, 2010, The M1 form of tumor-associated macrophages in non–small cell lung cancer is positively associated with survival time, BMC Cancer, 10, 112, 10.1186/1471-2407-10-112 · DOI · Paper page
- Fadok, 1992, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J Immunol, 148, 2207, 10.4049/jimmunol.148.7.2207 · DOI · Paper page
- McDonald, 1999, Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells, J Immunol, 163, 6164, 10.4049/jimmunol.163.11.6164 · DOI · Paper page
- Balasubramanian, 2003, Aminophospholipid asymmetry: a matter of life and death, Annu Rev Physiol, 65, 701, 10.1146/annurev.physiol.65.092101.142459 · DOI · Paper page
- Ran, 2002, Increased exposure of anionic phospholipids on the surface of tumor blood vessels, Cancer Res, 62, 6132
- Ran, 2005, Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice, Clin Cancer Res, 11, 1551, 10.1158/1078-0432.CCR-04-1645 · DOI
- Taylor, 2011, Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments, Semin Immunopathol, 33, 441, 10.1007/s00281-010-0234-8 · DOI · Paper page
- Utsugi, 1991, Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes, Cancer Res, 51, 3062
- He, 2007, Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids, Clin Cancer Res, 13, 5211, 10.1158/1078-0432.CCR-07-0793 · DOI
- Huang, 2005, A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice, Cancer Res, 65, 4408, 10.1158/0008-5472.CAN-05-0031 · DOI · Paper page
- He, 2011, Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells, EMBO Rep, 12, 358, 10.1038/embor.2011.28 · DOI · Paper page
- Freeman, 2010, TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity, Immunol Rev, 235, 172, 10.1111/j.0105-2896.2010.00903.x · DOI · Paper page
- Park, 2007, BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module, Nature, 450, 430, 10.1038/nature06329 · DOI · Paper page
- Park, 2008, Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor, Cell Death Differ, 15, 192, 10.1038/sj.cdd.4402242 · DOI · Paper page
- Balasubramanian, 1998, Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes, J Biol Chem, 273, 29272, 10.1074/jbc.273.44.29272 · DOI · Paper page
- Bondanza, 2004, Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo, J Exp Med, 200, 1157, 10.1084/jem.20040327 · DOI · Paper page
- He, 2009, Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma, Clin Cancer Res, 15, 6871, 10.1158/1078-0432.CCR-09-1499 · DOI
- Kenis, 2009, Targeting phosphatidylserine in anti-cancer therapy, Curr Pharm Des, 15, 2719, 10.2174/138161209788923903 · doi:10.2174/138161209788923903
- Digumarti, 2010, Phase II study of bavituximab plus paclitaxel and carboplatin in untreated locally advanced or metastatic non–small cell lung cancer: interim results, J Clin Oncol, 28, 7589, 10.1200/jco.2010.28.15_suppl.7589 · doi:10.1200/jco.2010.28.15_suppl.7589
- Gerber, 2011, Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors, Clin Cancer Res, 17, 6888, 10.1158/1078-0432.CCR-11-1074 · DOI
- Jain, 2010, Phase II study of bavituximab plus paclitaxel and carboplatin in locally advanced or metastatic breast cancer: interim results, J Clin Oncol, 28, 1062, 10.1200/jco.2010.28.15_suppl.1062 · DOI
- Luster, 2006, Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells, J Biol Chem, 281, 29863, 10.1074/jbc.M605252200 · DOI
- Ran, 2002, Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy, Int J Radiat Oncol Biol Phys, 54, 1479, 10.1016/S0360-3016(02)03928-7 · DOI · Paper page
- Szajnik, 2010, Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg), PLoS ONE, 5, e11469, 10.1371/journal.pone.0011469 · DOI · Paper page
- Yan, 2012, Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo, Cancer Immunol Immunother, 61, 1917, 10.1007/s00262-012-1250-4 · DOI
- Lima, 2009, Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner, Cancer Lett, 283, 168, 10.1016/j.canlet.2009.03.041 · DOI · Paper page
- Beatty, 2011, CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans, Science, 331, 1612, 10.1126/science.1198443 · DOI · Paper page
- Zhou, 2011, Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions, Int Immunopharmacol, 11, 890, 10.1016/j.intimp.2011.01.007 · DOI · Paper page
- Chen, 2004, Phosphatidylserine regulates the maturation of human dendritic cells, J Immunol, 173, 2985, 10.4049/jimmunol.173.5.2985 · DOI · Paper page
- Simeone, 2012, Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1, J Immunotoxicol, 9, 241, 10.3109/1547691X.2012.678021 · DOI
Cited by
Birge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J., Calianese, D., Barcinski, M., Brekken, R. A., Huang, X., Hutchins, J. T., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.11 · Cited by 725
Self-citationMacrophages in bone fracture healing: Their essential role in endochondral ossification
Schlundt, C., El Khassawna, T., Serra, A., Dienelt, A., Wendler, S., Schell, H., van Rooijen, N., Radbruch, A., Lucius, R., Hartmann, S., et al. (2018) · Bone · doi:10.1016/j.bone.2015.10.019 · Cited by 615
Next generation of immune checkpoint inhibitors and beyond
Marin-Acevedo, J. A., Kimbrough, E. O., & Lou, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01056-8 · Cited by 548
Exposure of phosphatidylserine on the cell surface
Nagata, S., Suzuki, J., Segawa, K., & Fujii, T. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.7 · Cited by 512
Myeloid-Derived Suppressor Cells
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.002 · Cited by 482
Metadata
- Authors
- Yin, Y., Huang, X., Lynn, K. D., & Thorpe, P. E.
- Venue
- Cancer Immunology Research
- Published
- 2013-10-01
- Volume
- 1
- Issue
- 4
- Pages
- 256-268
- ISSN
- 2326-6066 (ISSN-L)
- 2326-6074
- OpenAlex
- W2164839146
- Cited by
- 149
- References
- 9
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. https://app.cochat.ai/papers/10.1158/2326-6066.cir-13-0073
- The paper
- Yin, Y., Huang, X., Lynn, K. D., & Thorpe, P. E. (2013). Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-13-0073
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.